Medistim ASA (FRA:MD1)
Germany · Delayed Price · Currency is EUR 18.30
+0.45 (2.52%)
At close: Feb 20, 2026
Revenue by Geography
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Americas Revenue | 276.34M | 237.16M | 209.02M | |||||||||||
Americas Revenue Growth | 16.52% | 13.46% | 2.66% | |||||||||||
APAC Revenue | 80.93M | 65.46M | 82.98M | |||||||||||
APAC Revenue Growth | 23.64% | -21.12% | 5.04% | |||||||||||
EMEA Revenue | 177.39M | 170.16M | 154.93M | |||||||||||
EMEA Revenue Growth | 4.25% | 9.83% | 16.05% | |||||||||||
Third Party Products Revenue | 99.85M | 89.82M | 79.43M | |||||||||||
Third Party Products Revenue Growth | 11.16% | 13.08% | 4.74% |
Revenue Breakdown
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) | 54.84M | 61.34M | 64.37M | |||||||||||
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) Growth | -10.59% | -4.71% | 5.36% | |||||||||||
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) | 40.71M | 39.50M | 36.24M | |||||||||||
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) Growth | 3.06% | 9.00% | 10.86% | |||||||||||
Capital Sales - Flow Systems | 62.76M | 55.22M | 55.55M | |||||||||||
Capital Sales - Flow Systems Growth | 13.66% | -0.59% | 11.85% | |||||||||||
Capital Sales - Flow and Imaging Systems | 99.27M | 69.17M | 81.49M | |||||||||||
Capital Sales - Flow and Imaging Systems Growth | 43.51% | -15.11% | -5.73% | |||||||||||
Capital Sales - Flow Probes | 257.93M | 231.47M | 193.06M | |||||||||||
Capital Sales - Flow Probes Growth | 11.43% | 19.89% | 14.11% | |||||||||||
Capital Sales - Imaging Probes | 19.17M | 16.08M | 16.23M | |||||||||||
Capital Sales - Imaging Probes Growth | 19.20% | -0.92% | -4.72% | |||||||||||
Total Own Products Revenue | 534.67M | 472.78M | 446.94M | |||||||||||
Total Own Products Revenue Growth | 13.09% | 5.78% | 7.41% | |||||||||||
Third Party Products Revenue | 99.85M | 89.82M | 79.43M | |||||||||||
Third Party Products Revenue Growth | 11.16% | 13.08% | 4.74% |
Revenue Breakdown 2
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Third Party Products Revenue | 99.85M | 89.82M | 79.43M | |||||||||||
Third Party Products Revenue Growth | 11.16% | 13.08% | 4.74% | |||||||||||
Coronary Surgery Revenue | 421.36M | 379.05M | 365.64M | |||||||||||
Coronary Surgery Revenue Growth | 11.16% | 3.67% | 5.51% | |||||||||||
Vascular Surgery Revenue | 113.31M | 93.72M | 81.29M | |||||||||||
Vascular Surgery Revenue Growth | 20.90% | 15.29% | 16.88% |
Revenue by Geography 3
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Third Party Products Revenue | 99.85M | 89.82M | 79.43M | |||||||||||
Third Party Products Revenue Growth | 11.16% | 13.08% | 4.74% |
Key Performance Indicators
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) Units Sold | 21.94K | 23.54K | 26.06K | |||||||||||
PPP and Lease Revenue - Flow Procedures (PPP/Card Based) Units Sold Growth | -6.78% | -9.68% | -13.15% | |||||||||||
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) Units Sold | 8.12K | 7.48K | 8.04K | |||||||||||
PPP and Lease Revenue - Imaging and Flow Procedures (PPP/Card Based) Units Sold Growth | 8.60% | -7.05% | -24.93% | |||||||||||
PPP and Lease Revenue - Flow Systems (PPP/Lease) Units Sold | - | 4.00 | - | |||||||||||
PPP and Lease Revenue - Flow and Imaging Systems (PPP/Lease) Units Sold | 3.00 | 5.00 | 4.00 | |||||||||||
PPP and Lease Revenue - Flow and Imaging Systems (PPP/Lease) Units Sold Growth | -40.00% | 25.00% | - | |||||||||||
Capital Sales - Flow Systems Units Sold | 129.00 | 116.00 | 144.00 | |||||||||||
Capital Sales - Flow Systems Units Sold Growth | 11.21% | -19.44% | -3.36% | |||||||||||
Capital Sales - Flow and Imaging Systems Units Sold | 78.00 | 66.00 | 93.00 | |||||||||||
Capital Sales - Flow and Imaging Systems Units Sold Growth | 18.18% | -29.03% | -7.92% | |||||||||||
Capital Sales - Flow Probes Units Sold | 10.46K | 9.63K | 9.12K | |||||||||||
Capital Sales - Flow Probes Units Sold Growth | 8.58% | 5.63% | -8.34% | |||||||||||
Capital Sales - Imaging Probes Units Sold | 152.00 | 132.00 | 168.00 | |||||||||||
Capital Sales - Imaging Probes Units Sold Growth | 15.15% | -21.43% | -1.75% |
Updated Jun 30, 2025. Data Source: Fiscal.ai.